ALPS Medical Breakthroughs ETF (SBIO)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 26, 2024 | $1.17 | 2024-12-19 | 2024-12-19 |
| December 27, 2023 | $0.07 | 2023-12-21 | 2023-12-22 |
| December 27, 2019 | $0.02 | 2019-12-19 | 2019-12-20 |
| December 27, 2018 | $0.78 | 2018-12-20 | 2018-12-21 |
| December 28, 2017 | $0.58 | 2017-12-21 | 2017-12-22 |
Dividends Summary
- ALPS Medical Breakthroughs ETF has issued 5 dividend payments over the past 7 years
- The most recent dividend was paid 268 days ago, on December 26, 2024
- The highest dividend payed out to investors during this period was $1.17346 per share
- The average dividend paid during this period was $0.52 per share.
Company News
This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech equities.
Wall Street's newfound bullishness on small caps reflects a notable shift in market dynamics, with several analysts predicting continued growth.
These funds can take some of the risks out of these exciting but sometimes dangerous sectors.
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Monday, Dec. 20. “We are proud to announce our addition to the esteemed Nasdaq Biotechnology Index,” George Goldsmith, CEO and founder of Compass Pathways said. “Our inclusion in this index enables us to reach new audiences as we continue to execute on our clinical development of our investigational COMP360 psilocybin therapy in hopes of addressing the most challenging ...